AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Guided Therapeutics, Inc.
Video analysis: GTHP
All videosNo video analysis for this stock yet. Request one from our team.
News: GTHP
Guided Therapeutics Reaches Collaborative Agreement with Türkiye's Ministry of Health to Become Primary Screening Test for Cervical Cancer
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that it has reached an agreement with the Ministry of Health to co-develop LuViva for primary screening of cervical cancer in Türkiye. The first step of the collaborative agreement is to conduct an 800 patient clinical study to optimize LuViva's AI pattern recognition algorithms for real time detection of cellular changes that occur in the earliest stages of.
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
Guided Therapeutics, Inc. (OTC: QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distrib
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year. The four LuViva devices are expected to ship later this year, which will bring the total number of devices shipped to ele.
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today it had filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration (FDA). The study protocol was developed through interactions with FDA and enrolled 480 women referred to biopsy because of abnormal Pap a.
Similar companies
-
Biotricity, Inc.
BTCY
·
Other OTC
Compare
-
Aurora Spine Corporation
ASAPF
·
Other OTC
Compare
-
Perimeter Medical Imaging AI, Inc.
PYNKF
·
Other OTC
Compare
-
CareView Communications, Inc.
CRVW
·
Other OTC
Compare
-
United Health Products, Inc.
UEEC
·
Other OTC
Compare
-
VentriPoint Diagnostics Ltd.
VPTDF
·
Other OTC
Compare